Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer

Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer

Abstract Background Cancer-associated fibroblasts (CAFs) have been shown to support tumor development in a variety of cancers. Different markers were applied to classify CAFs in order to elucidate their impact on tumor progression. However, the exact mechanism by which CAFs enhance cancer developmen...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Anna Muchlińska, Anna Nagel, Marta Popęda, Jolanta Szade, Magdalena Niemira, Jacek Zieliński, Jarosław Skokowski, Natalia Bednarz-Knoll, Anna J. Żaczek
Format:	Artikel
Sprache:	English
Veröffentlicht:	BMC 2022-06-01
Schriftenreihe:	Cellular & Molecular Biology Letters
Schlagworte:	Cancer-associated fibroblast Luminal breast cancer Alpha-smooth muscle actin Osteopontin
Online Zugang:	https://doi.org/10.1186/s11658-022-00351-7

Ähnliche Einträge

Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility
von: Yoshinobu Kariya, et al.
Veröffentlicht: (2021-09-01)

Osteopontin and breast cancer metastasis: Possible role of genistein on the regulation of osteopontin
von: Kitboklang Khongsti, et al.
Veröffentlicht: (2021-11-01)

Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
von: Daniella Mattos, et al.
Veröffentlicht: (2024-09-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
von: Magdalena Niedolistek, et al.
Veröffentlicht: (2020-04-01)

Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
von: Marta Popeda, et al.
Veröffentlicht: (2021-03-01)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
von: Josip Maleš, et al.
Veröffentlicht: (2021-02-01)

Potential of osteopontin in the management of epithelial ovarian cancer
von: Cerne Katarina, et al.
Veröffentlicht: (2019-01-01)

Osteopontin in Cancer: Mechanisms and Therapeutic Targets
von: Yoshinobu Kariya, et al.
Veröffentlicht: (2022-08-01)

Osteopontin and Cancer: Insights into Its Role in Drug Resistance
von: Chengcheng Hao, et al.
Veröffentlicht: (2023-01-01)

Meta-analysis of Osteopontin splice variants in cancer
von: Yu An, et al.
Veröffentlicht: (2023-04-01)

Role of osteopontin in cancer development and treatment
von: Zhihua Yan, et al.
Veröffentlicht: (2023-10-01)

Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms
von: Bruna Prunes Pena Baroni Viana, et al.
Veröffentlicht: (2021-10-01)

Osteopontin as a tumor marker in ovarian cancer
von: Shikha Rani, et al.
Veröffentlicht: (2022-01-01)

Investigating the Role of Osteopontin (OPN) in the Progression of Breast, Prostate, Renal and Skin Cancers
von: Gautam Kundu, et al.
Veröffentlicht: (2025-01-01)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
von: Kalhara R. Menikdiwela, et al.
Veröffentlicht: (2022-11-01)

Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study
von: T U Kars, et al.
Veröffentlicht: (2023-01-01)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
von: Atif Ali Hashmi, et al.
Veröffentlicht: (2018-01-01)

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer
von: Serafin Morales Murillo, et al.
Veröffentlicht: (2021-03-01)

Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer
von: Zhao Fujun, et al.
Veröffentlicht: (2012-10-01)

LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER
von: M. V. Zavjalova, et al.
Veröffentlicht: (2016-02-01)

Clinical-radiomics nomogram based on the fat-suppressed T2 sequence for differentiating luminal and non-luminal breast cancer
von: Yaxin Guo, et al.
Veröffentlicht: (2024-10-01)

Osteopontin expression in reactive lesions of gingiva
von: Rathinam ELANAGAI, et al.
Veröffentlicht: (2015-02-01)

Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age
von: Runnak A Majid, et al.
Veröffentlicht: (2017-04-01)

Role of actin-binding proteins in prostate cancer
von: Fangzhi Fu, et al.
Veröffentlicht: (2024-07-01)

Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
von: Piotr Ziółkowski, et al.
Veröffentlicht: (2022-09-01)

Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
von: Zhuce Shao, et al.
Veröffentlicht: (2023-01-01)

Expression of Osteopontin and Cyclooxygenase-2 in relation to cellular proliferation, in non-tumor colonic mucosa, colonic adenomas and colon adenocarcinoma.
von: Inés Benedetti Padron, et al.
Veröffentlicht: (2021-01-01)

Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
von: Yin-Hsun Feng, et al.
Veröffentlicht: (2019-08-01)

Prognostic significance of serum osteopontin levels in small cell lung cancer
von: Chunhua Xu, et al.
Veröffentlicht: (2020-09-01)

Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
von: Mohammad Kamalabadi-Farahani, et al.
Veröffentlicht: (2022-09-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
von: Dorsay Sadeghian, et al.
Veröffentlicht: (2022-02-01)

Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin
von: Zhang Wen-zhi, et al.
Veröffentlicht: (2011-10-01)

Osteopontin in Cardiovascular Diseases
von: Kohsuke Shirakawa, et al.
Veröffentlicht: (2021-07-01)

MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
von: M. V. Zavyalova, et al.
Veröffentlicht: (2016-02-01)

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
von: Kamil Mieczkowski, et al.
Veröffentlicht: (2022-08-01)

Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer
von: Chengcheng Hao, et al.
Veröffentlicht: (2021-07-01)

Differentially expressed miRNAs in Luminal and Basal-like breast cancer
von: Ming-Juan ZHAO, et al.
Veröffentlicht: (2021-06-01)

Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case–control and systems biology study
von: Sepideh Mehrpour Layeghi, et al.
Veröffentlicht: (2020-10-01)

Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma
von: Krisztina Jámbor, et al.
Veröffentlicht: (2022-08-01)

Histopathological Patterns and Luminal Subtypes among Breast Cancer Patients in the Middle Euphrates Region of Iraq
von: Ahmed Mjali, et al.
Veröffentlicht: (2022-08-01)